Warning!  The information herein is a best effort by the company to make material information publicly available, and it may not meet with the standards required by other pertinent market entities.

Buying or selling this security on the basis of material nonpublic material information is prohibited under Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5 and 10b5-1 thereunder. Violators may be subject to civil and criminal penalties.


Chart


Analysis

 
 

News


Filings And Disclosures

KALY Independent Self Disclosures

PUBLISH TITLE PERIOD STATUS

DATE END DATE

08/22/2019 QUARTERLY REPORT 06/30/2019 A

08/22/2019 QUARTERLY REPORT 03/31/2019 A

OTC Disclosures & News

PUBLISH TITLE PERIOD STATUS

DATE END DATE

05/15/2019 Notification of Late Filing - Quarterly Report 03/31/2019 A

05/15/2019 Annual Report - Annual Report 12/31/2018 A

04/01/2019 Notification of Late Filing 12/31/2018 A

03/14/2019 Attorney Letter with Respect to Current Information 09/30/2018 A

03/13/2019 Quarterly Report 09/30/2018 A

03/13/2019 Officer/Director Disclosure 09/30/2018 A

03/13/2019 Quarterly Report 06/30/2018 A

03/13/2019 Officer/Director Disclosure - 06/30/2018 A

03/13/2019 Quarterly Report 03/31/2018 A

03/13/2019 Officer/Director Disclosure 03/31/2018 A

SEC Filings

FORM TYPE RECEIVED PERIOD END DATE

15-12G 08/06/2013

S-8 POS 08/05/2013

10-Q 05/20/2013 03/31/2013

10-Q 05/16/2013 03/31/2013

8-K 04/23/2013 04/19/2013

10-K 04/16/2013 12/31/2012

10-K 04/01/2013 12/31/2012

8-K 11/13/2012 11/13/2012

24B3 11/08/2012

8-K 11/07/2012 11/07/2012


Company Description

On November 15, 2018, Kali, Inc announced the acquisition of NCM Biotech which is the developer and owner of a patented botanical extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING ..." With the patented intellectual property (IP), to include the existing and ongoing research and development acquired from NCM Biotech, Kali now focuses on the development of pharmaceuticals to treat various illnesses, diseases and chronic pain as a symptom of various diagnoses. Kali also concentrates on the development of health and wellness therapies.